期刊文献+

淫羊藿苷对小鼠骨溶解模型OPG/RANKL基因及其蛋白表达的影响 被引量:3

Effect of Icariin on OPG/RANKL Gene and Protein Expression Influence of Mus Musculus Osteolysis Model
原文传递
导出
摘要 目的:研究不同剂量的淫羊藿苷对钛颗粒诱导小鼠骨溶解模型中OPG/RANKL基因及其蛋白表达的影响,探讨淫羊藿苷治疗关节置换术后骨溶解的作用机制。方法:取成年BALB/C小鼠40只,随机分为假手术组、阴性对照组、淫羊藿苷低剂量组及高剂量组,每组10只,除假手术组外,其余建立骨溶解模型后,各组按各自药物及剂量给予每日1次灌胃,共8周。停药次日取颅骨组织及外周血,运用real-time PCR及ELISA技术测定OPG/RANKL基因及其蛋白表达情况。结果:与阴性对照组相比,高剂量组OPG基因及蛋白表达显著上升(P<0.01),RANKL基因及蛋白表达显著下降(P<0.01);低剂量组无显著差异。结论:淫羊藿苷可以改变OPG/RANKL基因及蛋白表达量从而抑制骨溶解,这可能是淫羊藿苷治疗关节置换术后骨溶解的作用机制之一。 Objective: Study different doses of icariin on titanium particle-induced mouse osteolysis model of OPG / RANKL gene and its protein expression to explore the mechanism of icariin treatment arthroplasty osteolysis.Methods: 40 from adult BALB / C mice were randomly divided into sham group,the negative control group,the icariin group of low-dose and high dose group(n=10),The establishment of osteolysis model 2 weeks after surgery,In addition to the sham operation group,the rest of the establishment of osteolysis model each group according to their respective drug and dose given 1 times per day gavage for 8 weeks.Withdrawal the next day,take the skull tissue and peripheral blood.Use real-time PCR and ELISA techniques to determine the OPG / RANKL gene and its protein expression.Results:Compared with the negative control group,OPG gene and protein expression of the high dose group was significantly increased(P0.01),RANKL gene and protein expression decreased significantly(P0.01);There was no significant difference in the low dose group.Conclusions: Icariin can change the OPG / RANKL gene and protein expression to inhibit osteolysis,which may be one of the its mechanisms treatment arthroplasty osteolysis.
出处 《现代生物医学进展》 CAS 2012年第34期6647-6650,共4页 Progress in Modern Biomedicine
基金 黑龙江省教育厅科学技术研究项目(GC09C412-3)
关键词 淫羊藿苷 RANKL 骨溶解 关节置换 钛颗粒 Icariin RANKL Osteolysis Arthroplasty Titanium particles
  • 相关文献

参考文献20

  • 1GieGA,LinderL,LingRS. Impacted cancellous allografts and cement for revision total hip arthroplasty[J].Journal of Bone and Joint Surgery-British Volume,1993,(01):14-21.
  • 2Keams AE,Khosla S,Kostenuik PJ. Receptor activator of nuclear factor-κB ligand and osteoprotegerin regulation of bone remodeling in health and disease[J].Endocrine Reviews,2008,(02):155-192.doi:10.1210/er.2007-0014.
  • 3郑纺,王宝利,张镜宇,郭刚.改良TRIZOL法从矿化骨组织中提取总RNA[J].天津医药,2007,35(10):753-754. 被引量:14
  • 4Duffy GP,Berry D J,Rowland C. Primary uncemented total hip arthroplasty In patients《40years old:10-to 14-year results using first-generation proximally pamns-coated implants[J].Journal of Arthroplasty,2001.140-144.
  • 5Saleh KJ,Thongtrangan I,SchwarzEM. Osteolysis:medical and surgical approaches[J].Clinical Orthopaedics and Related Research,2004.138-147.
  • 6Koseki H,Matsumoto T,Ito S. Analysis of polyethylene particles isolated from periprosthetic tissue of loosened hip arthroplasty and comparison with radiographic appearance[J].Journal of Orthopaedic Science,2005,(03):284-290.doi:10.1007/s00776-005-0896-6.
  • 7Haynes DR,Crotti TN,Zreiqat H. Regulation of osteoclast activity in periimplant tissues[J].Biomaterials,2004,(20):4877-4885.doi:10.1016/j.biomaterials.2004.01.003.
  • 8Clohisy JC,Frazier E,Hirayama T. RANKL is an essential cytoldne mediator ofpolymethylmethacrylate particle induced osteoclastogenesis[J].Journal of Orthopaedic Research,2003.202-212.
  • 9Baumann B,Rader CP,Seufert J. Effects of polyethylene and TiAIV wear particles on expression of RANK,RANKL and OPG mRNA[J].Acta Orthopaedica Scandinavica,2004,(03):295-302.doi:10.1080/00016470410001222.
  • 10Kearns AE,Khosla S,Kostenuik PJ. Receptor activator of nuclear factor-κB ligand and osteoprotegerin regulation of bone remodeling in health and disease[J].Endocrine Reviews,2008,(02):155-192.doi:10.1210/er.2007-0014.

二级参考文献42

共引文献198

同被引文献21

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部